Latest Metaplasia Stories
Radiofrequency ablation (RFA) leads to remission for 91 percent of patients with dysplastic Barrett's esophagus.
A new study from researchers at the Hospital of the University of Pennsylvania reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's esophagus and high-grade dysplasia or early mucosal cancer have a high success rate, with durable results and a low risk of complications.
Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response.
Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at A*STARâ€™s Genome Institute of Singapore (GIS), and Principal Investigator Dr Wa Xian at A*STARâ€™s Institute of Medical Biology (IMB), together with their counterparts from the Harvard Medical School, the Brigham and Womenâ€™s Hospital in Boston, and the National University of Singapore, have made the striking finding that Barrettâ€™s esophagus work, published online in the journal Cell on...
Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously thought, according to this study.
Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously reported.
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.
SUNNYVALE, Calif., July 14 /PRNewswire/ -- BARRX Medical, Inc.
SUNNYVALE, Calif., June 28 /PRNewswire/ -- BARRX Medical Inc., a world leader in products to treat pre-cancerous tissue in the esophagus, reported today that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has published new guidelines approving the use of radiofrequency ablation for the eradication of dysplastic Barrett's esophagus. Barrett's esophagus is a precancerous condition that affects over 6.6 million people around the world and is caused by...
NEW ORLEANS, May 5 /PRNewswire/ -- Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term.
- A serpent whose bite was fabled to produce intense thirst.